Eric J. Daniels
Chief Development Officer & COODr. Eric J. Daniels, MD, MBA, is Chief Development Officer of Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) from April 20, 2026 and is its Chief Operating Officer since November 6, 2026. He was Chief Development Officer of Kiora Pharmaceuticals, Inc. (formerly known as EyeGate Pharmaceuticals, Inc.) from October 21, 2021 until April 17, 2026. He is Co-Founder and Director at Okogen, Inc. Dr. Daniels joined the Kiora Pharmaceuticals, Inc. on October 21, 2021. Dr. Daniels is a member of the medical advisory board of Bimini, LLC and served as its Consulting Chief Medical Officer from 2014 through October 2021. He has operating experience in biotechnology and medical device companies. Prior to joining EyeGate, he served as the CEO of OccuRx Pty Ltd as well as Co-Founder and Director of Bayon, both focused on the development of novel ophthalmic therapeutics. Eric is also a Co-Founder and Director of Okogen, Inc., a specialty ophthalmic biotechnology company and served as its Chief Operating Officer from 2015 through October 2021. Dr. Daniels previously served as Vice President — Marketing & Sales of Tensys Medical, Inc. from 2012 through 2016, He previously served as part of the leadership teams at Puregraft LLC and Cytori Therapeutics, Inc., serving in senior medical, R&D and commercial roles. He holds an MBA from the Anderson School of Management at the UCLA, where he also received his MD from the David Geffen School of Medicine at University of California Los Angeles. He received his BS in Molecular and Cell Biology from the University of California, Berkeley.
Positions
- Company NameCerenome, Inc.Stock CodeCNSYPositionChief Development Officer & COOColleagues
- MHMarc H. HedrickPresident, CEO & Director
- RJRichard J. HawkinsIndependent Chairman of the Board
- AJAndrew J. SimsVP & CFO
- RHRuss HavranekExecutive Vice President of Commercial and Corporate Strategy
- RARonald A. AndrewsChief Business Officer & Director
- AVAn van Es-JohanssonIndependent Director
- HCHoward ClowesIndependent Director
